← Back to Search

Test Lens for Presbyopia

N/A
Waitlist Available
Led By Ashley Tucker
Research Sponsored by Coopervision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how well existing soft lens wearers adjust to a new lens. After 2 weeks, success of the switch is evaluated.

Eligible Conditions
  • Presbyopia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Comfort Just After Lens Insertion

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Test LensExperimental Treatment1 Intervention
All participants wore the Test Lens for 2 weeks (Period 2)
Group II: Control LensActive Control1 Intervention
All participants wore the Control Lens for 2 weeks (Period 1)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Test Lens
2013
N/A
~320

Find a Location

Who is running the clinical trial?

Centre for Ocular Research & Education, CanadaOTHER
10 Previous Clinical Trials
2,246 Total Patients Enrolled
2 Trials studying Presbyopia
119 Patients Enrolled for Presbyopia
COREUNKNOWN
10 Previous Clinical Trials
2,246 Total Patients Enrolled
2 Trials studying Presbyopia
119 Patients Enrolled for Presbyopia
Coopervision, Inc.Lead Sponsor
163 Previous Clinical Trials
14,136 Total Patients Enrolled
17 Trials studying Presbyopia
827 Patients Enrolled for Presbyopia
~19 spots leftby Nov 2025